Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 노영석 | - |
dc.date.accessioned | 2018-04-03T07:38:03Z | - |
dc.date.available | 2018-04-03T07:38:03Z | - |
dc.date.issued | 2011-07 | - |
dc.identifier.citation | 환경생물학회, 2011, 29(3), P.113-125 | en_US |
dc.identifier.issn | 0494-4739 | - |
dc.identifier.issn | 2287-7851 | - |
dc.identifier.issn | 1226-9999 | - |
dc.identifier.uri | http://kiss.kstudy.com/thesis/thesis-view.asp?key=2936331 | - |
dc.identifier.uri | http://db.koreascholar.com/Article?code=5537 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11754/57232 | - |
dc.description.abstract | Adalimumab is the first fully humanized monoclonal anti-tumor necrosis factor alpha (TNF-α) antibody. This drug has been shown to be of benefit in patients with inflammatory diseases in which TNF-α is involved, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn`s disease. As the use of adalimumab is becoming more widespread, cutaneous side effects are being | en_US |
dc.language.iso | ko_KR | en_US |
dc.publisher | 한국환경생물학회 Korean Society Of Environmental Biology | en_US |
dc.subject | Adalimumab, | en_US |
dc.subject | TNF-α inhibitor | en_US |
dc.subject | TNF-α inhibitor | en_US |
dc.title | Adalimumab에 의한 고리육아종 | - |
dc.title.alternative | Granuloma Annulare Induced by Adalimumab | - |
dc.type | Article | en_US |
dc.relation.no | 07 | - |
dc.relation.volume | 49 | - |
dc.relation.page | 656-659 | - |
dc.relation.journal | 대한피부과학회지 | - |
dc.contributor.googleauthor | 김미란 | - |
dc.contributor.googleauthor | 이원철 | - |
dc.contributor.googleauthor | Kim, Mi-Ran | - |
dc.contributor.googleauthor | Lee, Won-Choel | - |
dc.contributor.googleauthor | Zubrzycki Igor Z. | - |
dc.relation.code | 2012211861 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | romio | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.